Sort
21,453 grants matching “tuberculosis”
A Randomized Trial of a Four Month Moxifloxacin-based Regimen for Treatment of
$214,217Marcus Barreto Conde · Johns Hopkins University · U19 · FY2007 · AI
Physiology of Mycobacterium Tuberculosis with Hibernating Ribosomes
$214,140Anil Kumar Ojha · Wadsworth Center · R21 · FY2020 · AI
Infectious Diseases Training program in Bolivia: South-South Training with Peru
$214,079Robert H Gilman · Johns Hopkins University · D43 · FY2017 · TW
An Intestinal Helminth Promotes Enteric Viral Infection Independent of Type 2 Immunity
$214,006Jakob H. Von Moltke · University Of Washington · R21 · FY2025 · AI
TB Diagnostics at the Point of Care
$214,001Christopher Gerard Cooney · Akonni Biosystems, Inc. · R43 · FY2010 · EB
Uganda HIV/TB COHRE Training Program
$213,961Christopher C. Whalen · Case Western Reserve University · U2R · FY2006 · TW
Control of Diseases in Zebrafish Research Facilities
$213,930Michael Lawrence Kent · Oregon State University · R24 · FY2008 · RR
Control of Diseases in Zebrafish Research Facilities
$213,930Michael Lawrence Kent · Oregon State University · R24 · FY2010 · RR
Control of Diseases in Zebrafish Research Facilities
$213,930Michael Lawrence Kent · Oregon State University · R24 · FY2009 · RR
Genome-targeted IL-23 receptor reporter rats for studying HLA-B27-dependent spondyloarthritis
$213,840Joel D Taurog · Ut Southwestern Medical Center · R21 · FY2019 · AR
CORE--Biosafety Core
$213,838Zahra Toossi · Case Western Reserve University · P30 · FY2007 · AI
FUNCTIONAL STUDIES OF GRANULOCYTE MEMBRANES
$213,819Boston University Medical Campus · R01 · FY2002 · DK
Core B: Integrative Genomics Core
$213,806Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2023 · AI
Acellular vaccines against Francisella tularensis
$213,750National Research Council Of Canada · R01 · FY2001 · AI
Defining the Impact of Immunodeficiency Virus Infection on Mycobacteria-Specific, Unconventional CD8+ T cells
$213,713Justin Greene · Oregon Health & Science University · R21 · FY2019 · AI
Role of pathogen-derived capping carbohydrates in altering immunity
$213,685Christine A Petersen · Iowa State University · R21 · FY2009 · AI
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS
$213,617Deepak Kaushal · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2009 · RR
Infectious Diseases Training program in Bolivia: South-South Training with Peru
$213,600Robert H Gilman · Johns Hopkins University · D43 · FY2018 · TW
Oral anti-TNF antibody for inflammatory bowel disease
$213,589Barbara S. Fox · Avaxia Biologics, Inc. · R43 · FY2010 · DK
DlaT as a transcriptional regulator in non-replicating Mycobacterium tuberculosis
$213,571Ruslana Bryk · Weill Medical Coll Of Cornell Univ · R21 · FY2012 · AI
Host proteins that interact with the BCG cell envelope
$213,546Mary Sloan Siegrist · University Of Massachusetts Amherst · R21 · FY2021 · AI
Sequencing and Epigenetics Core
$213,471Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2019 · AI
Research Training Program in Pulmonary Host Defense, Inflammation and Immunity
$213,436Thomas J Kelley · Case Western Reserve University · T32 · FY2008 · HL
The impact of IL-4 and IL-4-producing cells on protective immunity to tuberculosis
$213,412Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · AI
Protein-protein association in mycobacteria
$213,368Adrie Jc Steyn · University Of Alabama At Birmingham · R21 · FY2008 · AI